Skip to main content

Table 2 Demographic and clinical characteristics of subset participants with PET data

From: The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease

  Non-carriers (n = 35) Cognitively intact carriers (n = 19) Symptomatic carriers (n = 12)
M (SD)
Demographic and clinical variables
 Age (years) 34.69 (4.84) 33.95 (5.08) 42.25 (3.41)
 Education (years) 11.03 (4.16) 11.21 (3.15) 5.75 (3.14)
 MMSE 28.97 (.92) 28.68 (.88) 25.08 (3.23)
 GDS .94 (1.49) .63 (1.46) 2.75 (3.22)
Cognitive variables
 CERAD Word List Learning 20.91 (3.15) 20.05 (2.99) 12.50 (3.87)
 CERAD Word List Delayed Recall 7.69 (1.25) 7.05 (1.96) 2.92 (2.39)
 CERAD Word List Recognition 9.74 (.56) 9.84 (.37) 7.33 (2.27)
 CERAD CP- Copy 10.40 (1.03) 10.58 (.61) 9.50 (1.31)
 CERAD CP- Delayed Recall 9.51 (1.58) 10.05 (1.58) 3.83 (3.43)
 Phonemic Fluency (FAS) 32.54 (7.69) 36.74 (7.96) 29.17 (8.40)
 Semantic Fluency (Animals) 20.00 (3.66) 21.68 (4.70) 18.25 (3.93)
 Boston Naming Test (BNT-15) 13.86 (1.00) 13.58 (1.17) 13.00 (1.76)
  1. Note: Symptomatic carriers include participants with FAST scores of 2 and 3 indicating presence of SCD concerns and MCI, respectively
  2. Abbreviations: M mean, SD standard deviation, FAST Functional Assessment Staging test, MMSE Mini Mental State Exam, GDS Geriatric Depression Scale, CERAD Consortium to Establish a Registry for Alzheimer’s Disease, CP constructional praxis